Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma.

Front Immunol · 2024 · PMC11211265 · PMID 38947326

Europe PMC DOI

hedged sentence

0.1590

closest p · 3.2× alpha

0.1590

boldest claim

The sentences

did not reach statistical significancep=0.159not close (p > 0.1)

Any-grade ICANS was more frequent with axi-cel than tisa-cel but did not reach statistical significance (57% vs 39%; p=0.159).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.